CIK 0001178670
- Large accelerated filer
ALNYLAM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ALNY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770602661
- Phone
- +1 617-551-8200
- Business address
- 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
- Former names
- ALNYLAM PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $543,126
- in 2 filings
- Open-market sales, last 90 days
- $398,855
- in 1 filing
Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-15 | SHARP PHILLIP A Director | Exercise or conversion · Stock Option (right to buy) | −30,000 | 0 | ||
| 2022-08-05 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −149 | $215.03 | $32K | 1,692 |
| 2022-08-05 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −398 | $216.21 | $86K | 1,294 |
| 2022-08-05 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −440 | $217.61 | $96K | 854 |
| 2022-08-05 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −541 | $218.71 | $118K | 313 |
| 2022-08-05 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −99 | $219.53 | $22K | 214 |
| 2022-08-05 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −105 | $220.95 | $23K | 109 |
| 2022-08-05 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −5 | $224.00 | $1K | 104 |
| 2022-08-05 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −104 | $225.15 | $23K | 0 |
| 2022-08-04 | Tanguler Tolga EVP, Chief Commercial Officer | Shares withheld for taxes | −1,618 | $189.76 | $307K | 2,011 |
| 2022-08-04 | Tanguler Tolga EVP, Chief Commercial Officer | Shares withheld for taxes | −170 | $210.50 | $36K | 1,841 |
| 2022-08-04 | Poulton Jeffrey V. EVP, Chief Financial Officer | Shares withheld for taxes | −4,573 | $189.76 | $868K | 9,887 |
| 2022-08-04 | Poulton Jeffrey V. EVP, Chief Financial Officer | Shares withheld for taxes | −162 | $209.83 | $34K | 9,725 |
| 2022-08-04 | Poulton Jeffrey V. EVP, Chief Financial Officer | Shares withheld for taxes | −146 | $209.88 | $31K | 9,579 |
| 2022-08-04 | Poulton Jeffrey V. EVP, Chief Financial Officer | Shares withheld for taxes | −173 | $210.50 | $36K | 9,406 |
| 2022-08-04 | Garg Pushkal CMO & EVP Dev & Med Affairs | Shares withheld for taxes | −4,603 | $189.76 | $873K | 17,900 |
| 2022-08-04 | Garg Pushkal CMO & EVP Dev & Med Affairs | Shares withheld for taxes | −165 | $205.87 | $34K | 17,735 |
| 2022-08-04 | Garg Pushkal CMO & EVP Dev & Med Affairs | Shares withheld for taxes | −172 | $209.91 | $36K | 17,563 |
| 2022-08-04 | Garg Pushkal CMO & EVP Dev & Med Affairs | Shares withheld for taxes | −146 | $210.02 | $31K | 17,417 |
| 2022-08-04 | Vaishnaw Akshay President | Shares withheld for taxes | −5,479 | $189.76 | $1.0M | 18,919 |
Page 60 of 63 · 1,253 trades